Position in PCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,842,074
+$382,675 QoQ
Shares Held
112,025
+2.9% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#55
of 251 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. PCRX ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
This page
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in PCRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,842,074 | 112,025 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,459,399 | 108,823 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,765,067 | 68,202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,028,020 | 78,697 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,541,382 | 64,493 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $807,227 | 32,484 | Shares | Sole | 2025-05-14 | |
| 2023-06-30 | $260,735 | 6,507 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $265,550 | 6,507 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,390,615 | 36,017 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,766,599 | 33,213 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,732,209 | 29,712 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,245,410 | 29,421 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,619,836 | 26,921 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,507,576 | 26,921 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $424,942 | 7,003 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $490,840 | 7,003 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $514,803 | 8,603 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,071,158 | 17,817 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,428,338 | 27,222 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $912,753 | 27,222 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||